| Name | Title | Contact Details |
|---|
Columbia Laboratories is a specialty pharmaceutical company that develops and commercializes innovative products for women’s healthcare and endocrine-related conditions. Our FDA-approved products include formulations that treat infertility, menstrual irregularities and hormonal deficiencies. Columbia’s products utilize our proprietary Bioadhesive Delivery System (BDS), which leverages the principle of bioadhesion to administer medication. This technology can deliver many types of compounds, including hormones and peptides, providing numerous internal and licensing product development opportunities.
Arcadia Health Care is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Commonwealth adminitrators is a Lexington, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Driven by a vision to liberate patients from degenerative disease, BlueRock Therapeutics is ushering in a new era of cell-based medicines. Founded in 2016, BlueRock and its team of preeminent scientists are pioneering cell therapies that restore critical natural functions in the body, with an initial focus on severe brain and heart conditions. BlueRock`s culture is defined by scientific transparency, the highest ethical standards and an urgency to bring transformative treatments to all who would benefit.
Celator Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that is transforming the science of combination therapy and developing products to improve outcomes for patients with cancer. The Company is working to establish a new treatment paradigm in which rationally-designed, fully-integrated combination products replace combination regimens of individual agents. Celator`s proprietary technology platform, CombiPlex®, identifies the most effective synergistic ratio of the component drugs, optimizes the pharmacology of the drug combination prior to human clinical trials, allows simultaneous administration of the components as a single product and maintains the synergistic ratio of the components after administration thereby exposing tumor cells to the right amounts of drug for the right length of time.